Immunometabolic reprogramming of macrophages by miR-423-5p-enriched small extracellular vesicles delivered via glucose/ROS-responsive hydrogel for diabetic wound healing.
Chen M., Guo Q., Qin Z., Tang Z., He J., Xiang T.
Laboratory Study on Diabetic Foot, Chronic Wound, Chronic Inflammation, Immune Modulation, published in J Nanobiotechnology (2026) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Laboratory Study
- Journal
- J Nanobiotechnology (2026)
- Country
- England
- Reported sample size
- —
- Source database
- PubMed
- PMID
- 42458558
- DOI
- 10.1186/s12951-026-04685-8
Abstract (original English)
Chronic diabetic wounds remain a formidable clinical challenge due to a self-sustaining immunometabolic dysfunction. The hyperglycemic and pro-oxidative microenvironment locks infiltrating macrophages in a glycolysis-dependent pro-inflammatory state, actively suppressing the phenotypic switch to pro-reparative M2 polarization and severely impairing angiogenesis. Current single-target interventions fail to disrupt this vicious inflammatory-metabolic cycle, underscoring an urgent need for strategies capable of spatiotemporally resetting local immune homeostasis. In this study, the pro-reparative capacity of ADSCs-EVs and UCMSCs-EVs was systematically compared through a panel of in vitro functional assays (proliferation, migration, tube formation, and macrophage polarization) and a diabetic mouse wound model. Small RNA sequencing was employed to identify a key effector miRNA enriched in UCMSCs-EVs, and its target regulatory mechanism was validated through miRNA mimic transfection combined with HDDC3 overexpression rescue experiments. Meanwhile, a glucose/ROS dual-responsive injectable hydrogel (DCH) was constructed from oxidized dextran, carboxymethyl chitosan, and phenylboronic acid-modified hyaluronic acid via physical mixing and dynamic double crosslinking through Schiff-base and boronate ester bonds, enabling the pathology-triggered, on-demand release of EVs. Comparative bioac
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level AMeta-analysisPubMed
Efficacy of Stem Cell-Derived Exosomes in Promoting Diabetic Foot Ulcer Healing: A Meta-Analysis of Preclinical Animal Studies.
Meta-analysis on Diabetic Foot, Chronic Wound, published in J Diabetes Res (2026) — summary generated from the PubMed abstract.
- 2026
J Diabetes Res - Level AMeta-analysisEurope PMC
Bone marrow-derived mesenchymal stem cells combined with intramuscular injection promote the healing of diabetic foot ulcers: a systematic review and meta-analysis
Meta-analysis with a reported sample of 2059 on Diabetic Foot, Chronic Wound, published in Front Endocrinol (Lausanne) (2026) — summary generated from the PubMed abstract.
- 2026
- n = 2059
Front Endocrinol (Lausanne) - Level AMeta-analysisEurope PMC
Comparative efficacy of advanced therapeutic modalities for diabetic foot ulcers: a systematic review and meta-analysis including NPWT, stem cells, ESWT, and bioengineered treatments
Meta-analysis on Diabetic Foot, published in Front Bioeng Biotechnol (2026) — summary generated from the PubMed abstract.
- 2026
Front Bioeng Biotechnol - Level AMeta-analysisPubMed
Therapeutic potential of adipose-derived stem cells for diabetic foot ulcers: a systematic review and meta-analysis.
Meta-analysis on Diabetic Foot, Chronic Wound, published in Diabetol Metab Syndr (2025) — summary generated from the PubMed abstract.
- 2025
Diabetol Metab Syndr6 citations - Level AMeta-analysisPubMed
A meta-analysis on application and prospect of cell therapy in the treatment of diabetes mellitus.
Meta-analysis on Diabetic Foot, Autoimmune Research, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cell Res Ther - Level AMeta-analysisEurope PMC
Comparison of the efficacy of 12 interventions in the treatment of diabetic foot ulcers: a network meta-analysis
Meta-analysis with a reported sample of 356 on Diabetic Foot, Chronic Wound, published in PeerJ (2025) — summary generated from the PubMed abstract.
- 2025
- n = 356
PeerJ1 citations